{"database": "openregs", "table": "documents", "rows": [["FDA-1975-N-0012-0392", "FDA", "FDA-1975-N-0012", "FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Productos Urologos de Mexico, S.A. de C.V., Mexicali Baja California Norte 21397 Mexico", "Other", "Letter(s)", "2014-03-16T04:00:00Z", 2014, 3, "2014-03-16T04:00:00Z", null, "2014-03-16T14:56:25Z", null, 0, 0, "09000064814b00c6"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1975-N-0012-0392"], "units": {}, "query_ms": 0.3656110493466258, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}